Home > News > MBCN in the News

Click on title to read the full article.

some-metastatic-cancers-are-more-curable-than-others

January 22, 2014

By Katherine O'Brien, ihatebreastcancer.wordpress.com blog

Last week’s Keller/Adams social media controversy inspired countless blog posts, print articles and editorials. Like remoras to a shark, everyone hustled to attach themselves to this issue.

MBCN responds: Bill Keller's Misguided NYTimes Op-Ed piece

January 13, 2014

By MBCNbuzz blog

Bill Keller’s op-ed piece on “Heroic Measures”  (January 12, 2014)  contains egregious factual errors. It also misrepresents what metastatic breast cancer is and how it is treated.

Dr. Julie Gralow Discusses the SWOG S0500 Trial

December 14, 2013

By Onclive

Julie R. Gralow, MD, director, Breast Medical Oncology, Seattle Cancer Care Alliance, clinical research division, member, Fred Hutchinson Cancer Care Center, professor, Medical Oncology Division, University of Washington School of Medicine, discusses the SWOG S0500 trial, which evaluated different treatments in patients with metastatic breast cancer who had elevated circulating tumor cell (CTC) levels.
- See more at: http://www.onclive.com/conference-coverage/sabcs-2013/Dr-Gralow-on-SWOG-S0500#sthash.vVNBrAnx.dpuf

Living with breast cancer when there's no cure

December 7, 2013

By Milwaukee Wisconsin Journal Sentinel

When Ginny Knackmuhs beat early-stage breast cancer and had routine checkups during the years that followed, she thought the disease was behind her. But in 2009, she was shocked to receive another diagnosis of breast cancer. This time it was metastatic, the most advanced kind.


UM researchers take new view in understanding metastatic breast cancer

October 21, 2013

By Scott Dance, Baltimore Sun

Focus on 'microtentacles' aims to prevent disease's ability to spread

Breast cancer kills when rogue tumor cells spread through the bloodstream, squeezing through microscopic gaps to inundate organs until they fail. But what if that spread could be prevented, the cells left free-floating to be crushed in capillaries or to self-destruct instead?

A team of researchers at the University of Maryland School of Medicine, joined by entrepreneurs and other academics, has been exploring that question for nearly a decade. What they have found challenges the basis for most breast cancer research and treatment, which focus on preventing tumor cells from multiplying.

Metastatic breast cancer - 'it's like getting all four tires flattened'

September 19, 2013

By Claudia Feldman, Houston Chronicle

Lori's complete story: Parts 1 and 2

Lori Sumako was your perfect, stage 1 breast cancer patient.

She followed all of her doctor's orders. She endured the surgery and chemotherapy without (too many) complaints. She and husband Rick Mitchell gave thanks for each year that she was cancer-free.

Fighting metastatic breast cancer one day, one week, one month at a time

August 23, 2013

By Houston chronicle Boomertown blog

Lori Sumako was your perfect, stage 1 breast cancer patient.

She followed all of her doctor’s orders. She endured the surgery and chemotherapy without (too many) complaints. She and husband Rick Mitchell gave thanks for each year that she was cancer-free.
Five years later, Sumako, a labor and delivery nurse, was told she was cured. A year after that, she started to believe it.

MBCN TO HOLD ANNUAL METASATIC BREAST CANCER CONFERENCE WITH MD ANDERSON CANCER CENTER ON SEPTEMBER 20-22, 2013

July 18, 2013

By MBCN Press Release

NEW YORK-JULY 18, 2013-Hundreds of metastatic breast cancer patients will convene in Houston for the Metastatic Breast Cancer Network's (MBCN's) 7th Annual National Conference presented in conjunction with MD Anderson Cancer Center on September 20-22, 2013. "We're really excited to offer expanded breakout sessions and networking opportunities," says conference chair and MBCN board member Deb Tincher. "This year's theme is ‘New Directions in Metastatic Breast Cancer.' Our expert speakers will address cutting-edge developments in treating metastatic breast cancer as well as everyday issues confronting people living with the disease."

Metastatic Breast Cancer Network Names Shirley Mertz New President

January 15, 2013

The Metastatic Breast Cancer Network (MBCN) announced the following leadership changes, effective as of January 1, 2013. Shirley Mertz is the new President, replacing former president Michele Przypyszny. Ginny Knackmuhs will serve as Vice President. New board member Katherine O’Brien replaces Kathy Coursey-Boes. Katherine will serve as Secretary and Public Relations Chair. Board members Joani Gudeman and Deb Tincher continue to serve as Chair of Outreach and Volunteers and Chair of Conferences and Fundraising, respectively.

Advanced breast cancer community advocates for more support

January 15, 2013

Ginny Knackmuhs, 61, of Wyckoff, N.J. was diagnosed with stage IV metastatic breast cancer in 2009. She remembers well the frustrating experience of searching for information and trying to identify with resources based on others’ recommendations. Ginny is now a board member of Metastatic Breast Cancer Network, one of 13 advocacy organizations that worked with Novartis Pharmaceuticals Corporation to create Count Us, Know Us, Join Us, a campaign that was created to amplify the voice of people living with advanced breast cancer.

 1 2 3 >  Last ›